A detailed history of Tekla Capital Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Tekla Capital Management LLC holds 210,789 shares of BMRN stock, worth $14 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
210,789
Previous 300,089 29.76%
Holding current value
$14 Million
Previous $29.2 Million 37.39%
% of portfolio
0.72%
Previous 1.12%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$86.68 - $100.3 $7.74 Million - $8.96 Million
-89,300 Reduced 29.76%
210,789 $18.3 Million
Q1 2023

May 10, 2023

BUY
$87.74 - $117.27 $6.08 Million - $8.13 Million
69,299 Added 30.03%
300,089 $29.2 Million
Q4 2022

Feb 10, 2023

BUY
$80.93 - $108.63 $6.46 Million - $8.67 Million
79,843 Added 52.89%
230,790 $23.9 Million
Q3 2022

Nov 01, 2022

BUY
$82.16 - $96.94 $1.88 Million - $2.22 Million
22,943 Added 17.92%
150,947 $12.8 Million
Q1 2021

May 14, 2021

SELL
$74.73 - $90.69 $11.2 Million - $13.6 Million
-150,326 Reduced 54.01%
128,004 $9.67 Million
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $3.45 Million - $4.28 Million
-47,492 Reduced 14.58%
278,330 $24.4 Million
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $5.78 Million - $10.5 Million
80,460 Added 32.79%
325,822 $24.8 Million
Q2 2020

Aug 13, 2020

SELL
$79.55 - $124.22 $2.01 Million - $3.14 Million
-25,251 Reduced 9.33%
245,362 $30.3 Million
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $424,437 - $575,966
-5,947 Reduced 2.15%
270,613 $22.9 Million
Q4 2019

Feb 13, 2020

BUY
$64.27 - $86.37 $1.98 Million - $2.66 Million
30,797 Added 12.53%
276,560 $23.4 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $1.9 Million - $2.22 Million
23,677 Added 10.66%
245,763 $21.1 Million
Q1 2019

May 14, 2019

BUY
$84.2 - $98.62 $1.23 Million - $1.44 Million
14,652 Added 7.06%
222,086 $19.7 Million
Q4 2018

Feb 13, 2019

BUY
$80.14 - $106.07 $5.36 Million - $7.1 Million
66,896 Added 47.6%
207,434 $17.7 Million
Q2 2018

Aug 13, 2018

SELL
$76.01 - $99.03 $10.7 Million - $13.9 Million
-140,538 Reduced 50.0%
140,538 $13.2 Million
Q1 2018

May 14, 2018

SELL
$77.67 - $92.63 $16.2 Million - $19.3 Million
-208,669 Reduced 42.61%
281,076 $22.8 Million
Q4 2017

Feb 14, 2018

SELL
$80.76 - $95.13 $969,120 - $1.14 Million
-12,000 Reduced 2.39%
489,745 $43.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
501,745
501,745 $45.6 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.